Cover Image
市場調查報告書

Flurbiprofen的中國市場分析

Investigation Report on China Flurbiprofen Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 333481
出版日期 內容資訊 英文 20 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Flurbiprofen的中國市場分析 Investigation Report on China Flurbiprofen Market, 2010-2019
出版日期: 2015年06月18日 內容資訊: 英文 20 Pages
簡介

非類固醇消炎劑 (NSAID) ,其化學結構與類固醇完全不相同,不過,帶來同樣的抗發炎、抗風濕作用。還有由於比類固醇副作用都,使用於包含成藥的各種藥物。中國的NSAID市場,2014年達到50億人民幣以上。其中功效特別高的是Flurbiprofen,在中國上市以來,急速擴大著銷售額。2005年是200萬人民幣以下的市場規模,此後以64.9%年複合成長率(CAGR) 成長,2014年達4億6600萬人民幣。

本報告提供中國的Flurbiprofen的市場相關分析,整體市場規模和國內價格趨勢,各企業、各投藥形態的市場佔有率,主要製造商簡介,今後的市場趨勢預測等調查評估。

第1章 Flurbiprofen的相關概念

  • 症狀
  • 全球市場的銷售情形

第2章 中國的Flurbiprofen市場概況

  • 中國國內的Flurbiprofen專利的申請、認證情形
  • 主要製造商
  • 市場規模

第3章 Flurbiprofen銷售情形分析 (過去5年份)

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售量

第4章 中國的Flurbiprofen市場:主要廠商的市場佔有率分析 (過去5年份)

  • 市場佔有率 (銷售額為基礎)
  • 市場佔有率 (銷售量為基礎)

第5章 中國的Flurbiprofen市場:各劑型分析 (過去5年份)

  • 各劑型的市場佔有率 (銷售額為基礎)
  • 各劑型的市場佔有率 (銷售量為基礎)

第6章 Flurbiprofen的醫院用標準價格

  • 三笠製藥 掛川工廠 (日本)
  • Beijing Tide Pharmaceutical Co., Ltd (商標名:Kaifen)

第7章 中國國內的Flurbiprofen的主要製造商

  • Beijing Tide Pharmaceutical Co., Ltd
  • 三笠製藥

第8章 中國的Flurbiprofen市場未來展望 (今後5年份)

  • 市場規模的預測
  • 競爭環境預測

圖表一覽

目錄
Product Code: 1506223

Non-steroidal anti-inflammatory drug (NSAID) has a totally different chemical structure from steroids which have a similar anti-inflammatory antirheumatic action. NSAID can also provide analgestic and antipyretic effects with fewer side effects compared with steroids. NSAID, be it nonprescription one or prescription one, has been the most widely used in the clinic. The market size of NSAID in China exceeded CNY 5 billion in 2014. Some varieties of NSAID have become OTC drugs in China since they are very common in the clinic.

By inhibiting the activity of cyclooxygenase and thereby the synthesis of prostaglandins, flurbiprofen is able to have pain-killing and fever-reducing effects. As flurbiprofen's molecular structure involves a fluorine atom, it has stronger effects even in small doses compared with similar drugs. Flurbiprofen ranks first in NSAIDs.

After entering China, flurbiprofen develops fast with annual sales value rising from less than CNY 2 million in 2005 to CNY 466 million in 2014 and CAGR during this period reaching up to 64.9%. Currently, flurbiprofen in the Chinese market mainly come from the following two companies: Beijing Tide Pharmaceutical Co., Ltd and MIKASA SEIYAKU CO.,LTD, the former having the larger market share of 99% for sales value in 2014.

The market size of flurbiprofen in China is expected to keep growing in the next few years in China.

Readers can get at least the following information from this report:

  • market size of flurbiprofen in China
  • competitive landscape of flurbiprofen in Chinese market
  • price of flurbiprofen made by different enterprises in China
  • market outlook of flurbiprofen in China

The author suggests the following groups of people purchase this report:

  • manufacturers of NSAID
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

Table of Contents

1. Related Concepts of Flurbiprofen

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Flurbiprofen in China

  • 2.1. Patent and Approval Status of Flurbiprofen in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Flurbiprofen in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Flurbiprofen in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Sales Status of Dosage Forms of Flurbiprofen in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Flurbiprofen in Chinese Hospitals in 2014

6.1MIKASA SEIYAKU CO.,LTD KAKEGAWA FACTORY (JA)

  • 6.2. Beijing Tide Pharmaceutical Co., Ltd (Trade Name: Kaifen)

7. Major Manufacturers of Flurbiprofen in Chinese Market, 2010-2014

  • 7.1. Beijing Tide Pharmaceutical Co., Ltd
  • 7.2. MIKASA SEIYAKU CO., LTD

8. Market Outlook of Flurbiprofen in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Selected Charts

  • Chart Approval Information of Flurbiprofen in China
  • Chart Sales Status of Flurbiprofen in China
  • Chart Sales Value of Flurbiprofen in China, 2010-2014
  • Chart Sales Value of Flurbiprofen in Some Regions in China, 2010-2014
  • Chart Sales Volume of Flurbiprofen in China, 2010-2014
  • Chart Sales Volume of Flurbiprofen in Some Regions in China, 2010-2014
  • Chart Market Share of Major Manufacturers of Flurbiprofen in China, 2010-2014
  • Chart Sales Value and Market Share of Flurbiprofen Made by Beijing Tide in China, 2010-2014
  • Chart Sales Value and Market Share of Flurbiprofen Made by MIKASA SEIYAKU(JA) in China, 2010-2014
  • Chart Sales Value and Market Share of Flurbiprofen Cream in China, 2010-2014
  • Chart Sales Value and Market Share of Flurbiprofen Injection in China, 2010-2014
  • Chart Price of Flurbiprofen Made by MIKASA SEIYAKU CO.,LTD KAKEGAWA FACTORY (JA) in Some Chinese Cities in 2014
  • Chart Price of Flurbiprofen Made by Beijing Tide Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Back to Top